NABP’s website and systems, including the telephone and fax lines, will be unavailable due to system maintenance from 12 PM Friday, August 26, 2016 until 10 AM on Sunday, August 28, 2016. During this time, NABP’s testing and license transfer registration; score results; CPE Monitor service; VPP, VIPPS, VAWD, and DMEPOS applications; PPAD; and publication ordering, will be unavailable.


Medication Error Reporting: CQI Programs Offer Avenue to Vital Follow-Up

Topics: Continuous quality improvement

Originally published in the January 2011 NABP Newsletter

Patient safety advocates have long emphasized the importance of documenting medication errors as a crucial tool in preventing future adverse medical events. Even before the Institute of Medicine’s landmark 1999 report, “To Err Is Human: Building a Safer Health Care System,” brought the issue to the attention of the public, medication error reporting was seen as an integral and vital element of programs designed to lessen the likelihood of dangerous mistakes and increase the quality and safety of patient care. At least 27 states require hospitals and/or other medical facilities to report serious medical errors, and 17 states mandate that pharmacies implement continuous quality improvement (CQI) programs. In varied pharmacy environments, CQI programs and error reporting have proven useful in helping to modify systems and procedures in order to prevent recurring errors and improve patient safety.

Read the full article, “Medication Error Reporting: CQI Programs Offer Avenue to Vital Follow-Up,” on the NABP Web site or in the January 2011 NABP Newsletter (PDF).